Indian markets are likely to continue with their upmove on Friday as global cues are positive. The two key data announced yesterday post the market hours left a lot be desired. The IIP for the month of May came in sharply lower at 3.2%, which is the slowest in the last seven months, while retail inflation jumped to 5%, which could once again make a case for further rate hikes by the RBI. Infosys will be in focus as it is due to announce its quarterly earnings today.  

The stocks that are likely to witness significant movement on the bourses on Friday are Karnataka Bank, Essar Ports, Vikrangee, Ashok Leyland and Goodluck India.

Dr. Reddy's Laboratories has launched Hydroxychloroquine Sulfate Tablets USP, 200 mg, a generic version of Plaquenil Tablets, in the US market. The drug was earlier approved by the US Food and Drug Administration (USFDA).

Diversified company L&T's construction arm has received two Water & Effluent Treatment orders from Madhya Pradesh corporation and Tirunelveli Municipal Corporation.

Equity bellwether indices touched their lifetime highs, but the broader markets refused to join the party and are yet to recover.

Alembic Pharmaceuticals has informed that the company has received tentative approval for its abbreviated new drug Ticagrelor Tablets, 90 mg.

The company stated that this acquisition will help Cipla gain market share and grow in OTC segment. The expected time for completion of this transaction is September 201

In recent times, we see that the performance of the large-cap funds was a bit lower than the benchmark, although they are considered to be one of the safest options in the equity funds category. 

Following stocks are close to their 52-week low as at 12.53 p.m. on July 12, 2018.

The company has executed a Concession Agreement with North Delhi Municipal Corporation (North DMC) for the redevelopment of multi-level car parking at Gandhi Maidan in Delhi. This development has pushed the share price of the company up by 2 per cent.